NCT06702007

Brief Summary

The goal of this project is to transform a successful, face-to-face harm-reduction treatment (HaRT-A) into a digital format, creating eHaRT-A. This new platform is specifically designed for people who have experienced homelessness and an alcohol use disorder (AUD), living within the framework of permanent, supportive, Housing First (HF) facilities. We hypothesize eHaRT-A will be more effective than the standard HF services in reducing alcohol-related harm and improving the overall quality of life for participants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P25-P50 for phase_3

Timeline
16mo left

Started Jan 2025

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Jan 2025Aug 2027

First Submitted

Initial submission to the registry

November 19, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 22, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

January 20, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

1.9 years

First QC Date

November 19, 2024

Last Update Submit

July 2, 2025

Conditions

Keywords

TelehealthAlcohol-Related HarmCommunity Based Participatory ResearchLived experience of chronic homelessness

Outcome Measures

Primary Outcomes (4)

  • Change in physical and mental-health related quality of life from baseline through 3-month follow-up as measured by the EQ-5D-5L

    The EQ-5D-5L is a psychometrically sound, 5-item, 5-point Likert scale measure that comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Its summary score will reflect participants' health-related quality of life (HRQoL) as a primary outcome.

    Baseline through 3-month follow-up

  • Change in typical and peak alcohol quantity consumed from baseline through 3-month follow-up as assessed by the AQUA.

    The Alcohol Quantity and Use Assessment (AQUA) was created by the research team for previous studies with a similar population and will be used to record the quantity of alcohol consumed on participants' heaviest and typical drinking days in the past two weeks. Scores are expressed in number of standard drinks with higher numbers indicating heavier drinking.

    Baseline through 3-month follow-up

  • Change in alcohol-related harm from baseline through 3-month follow-up as assessed by the SIP-2R.

    The Short Inventory of Problems (SIP-2R) is a 15-item, Likert-scale questionnaire that measures social, occupational and psychological alcohol-related problems. The summary score will serve as the alcohol-related problems outcome measure.

    Baseline to 3-month follow-up

  • Feasibility of eHaRT-A within Housing First

    Feasibility will be assessed as ease of enrollment of participants into the study as well as ability to retain participants during the intervention portion of the study (i.e., percentage screened who expressed interest, qualified, and completed eHaRT-A).

    Baseline to 3-month follow-up.

Secondary Outcomes (3)

  • Change in motivation/readiness/importance/confidence to engage in harm reduction from baseline through 3-month follow-up as assessed by the MTC.

    Baseline through 3-month follow-up

  • Change in alcohol frequency from baseline through 3-month follow-up as assessed by the ASI.

    Baseline through 3-month follow-up

  • Change in biochemical verification of EtG from baseline to 3-month follow-up.

    Baseline to 3-month follow-up

Other Outcomes (5)

  • Change in eHaRT receipt/enactment outcomes from baseline to 1-month follow-up as assessed by the SHaRE form.

    Baseline through 1-month follow-up.

  • Change in pain from baseline through 3-month as assessed by the BPI.

    Baseline through 3-month follow-up

  • eHaRT-A participant feedback at follow-up.

    1- or 3- month follow-up.

  • +2 more other outcomes

Study Arms (2)

Housing First As Usual

NO INTERVENTION

Housing First as usual includes housing provision and management, fulfillment of basic needs (e.g., food, clothing), nursing/medical services and case management.

Housing First + eHaRT-A

EXPERIMENTAL

HaRT-A comprises three concrete treatment components: 1) measurement and participant-led tracking of indicators of alcohol-related harm (e.g., number of drinks, blackouts), 2) elicitation of harm-reduction and health related quality of life (HRQoL) goals (e.g., drink slower, eat healthier, reconnect with family), and 3) discussion of safer-drinking strategies (e.g., taking B-complex vitamins, eating prior to or during alcohol use, avoiding mixing alcohol and other drugs). HaRT-A honors community representation within harm-reduction intervention development and acknowledges the larger forces (familial, community, geopolitical) at play in substance use, thus emphasizing the wisdom of the participant in defining their own pathway to recovery.

Behavioral: eHaRT-A

Interventions

eHaRT-ABEHAVIORAL

Adaptation of the Harm Reduction Treatment for Alcohol (HaRT-A) into a digital telehealth platform facilitating harm reduction treatment via patient-provider video sessions (eHaRT-A). eHaRT-A will include the three treatment components from the efficacious HaRT-A. eHaRT-A will be delivered during one-on-one sessions through video conferencing with interactive features (i.e., personalized feedback tracked over time and screen sharing).

Housing First + eHaRT-A

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being at least 21 years of age
  • Speak English fluently
  • Currently a registered client at one of the Housing First sites
  • Currently drinking (has used alcohol in the past 2 weeks)
  • Meeting criteria for "current" (e.g., past-year) AUD according to the Diagnostic and Statistical Manual of Mental Health Disorders, Fifth Edition (determined as scoring \>= 2 on the SCID-5-CV)

You may not qualify if:

  • Enrollment in any related treatment studies (including studies by this research team)
  • Refusal or inability to consent
  • Constituting a risk to the safety and security of residents or staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Downtown Emergency Service Center

Seattle, Washington, 98104, United States

RECRUITING

Related Publications (4)

  • Collins SE, Duncan MH, Saxon AJ, Taylor EM, Mayberry N, Merrill JO, Hoffmann GE, Clifasefi SL, Ries RK. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial. Lancet Psychiatry. 2021 Apr;8(4):287-300. doi: 10.1016/S2215-0366(20)30489-2. Epub 2021 Mar 10.

    PMID: 33713622BACKGROUND
  • Collins SE, Malone DK, Clifasefi SL, Ginzler JA, Garner MD, Burlingham B, Lonczak HS, Dana EA, Kirouac M, Tanzer K, Hobson WG, Marlatt GA, Larimer ME. Project-based Housing First for chronically homeless individuals with alcohol problems: within-subjects analyses of 2-year alcohol trajectories. Am J Public Health. 2012 Mar;102(3):511-9. doi: 10.2105/AJPH.2011.300403. Epub 2012 Jan 19.

    PMID: 22390516BACKGROUND
  • Collins SE, Clifasefi SL, Nelson LA, Stanton J, Goldstein SC, Taylor EM, Hoffmann G, King VL, Hatsukami AS, Cunningham ZL, Taylor E, Mayberry N, Malone DK, Jackson TR. Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder. Int J Drug Policy. 2019 May;67:24-33. doi: 10.1016/j.drugpo.2019.01.002. Epub 2019 Mar 6.

    PMID: 30851620BACKGROUND
  • Tsemberis S, Gulcur L, Nakae M. Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health. 2004 Apr;94(4):651-6. doi: 10.2105/ajph.94.4.651.

    PMID: 15054020BACKGROUND

Related Links

MeSH Terms

Conditions

AlcoholismHarm Reduction

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersBehavior

Study Officials

  • Tessa Frohe, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emily Taylor

CONTACT

Tessa Frohe, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Psychiatry & Behavioral Sciences

Study Record Dates

First Submitted

November 19, 2024

First Posted

November 22, 2024

Study Start

January 20, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

July 8, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

The proposed research involves participants from Housing First programs serving highly vulnerable populations, including those experiencing chronic homelessness and substance use disorders. Historical misuse of data on stigmatized behaviors has caused significant harm, including stigma and misrepresentation in politicized media narratives. Sharing individual participant data (IPD) risks breaching anonymity in tight-knit communities and undermining ethical commitments to community-based participatory research (CBPR), which prioritizes data use for the community's benefit. Given these risks, we do not plan to share IPD beyond the specific aims of this study.

Locations